New insider activity at Chemed ( (CHE) ) has taken place on March 4, 2025.
EVP Spencer Lee recently executed a significant transaction by selling 1,326 shares of Chemed stock, amounting to a total value of $785,323. This move highlights a notable shift in the executive’s investment strategy.
Recent Updates on CHE stock
Chemed Corporation’s recent earnings report and call highlighted strong performance in its VITAS Healthcare segment, driven by strategic acquisitions and expansion, notably in Florida, which led to a 17.4% increase in net patient revenue. The acquisition of Covenant Health’s hospice assets significantly contributed to this growth. However, the Roto-Rooter division faced challenges with a 2.9% revenue decline due to decreased residential revenue and call volume. Chemed’s financial position remains strong, with significant cash reserves and no long-term debt, allowing for substantial share repurchases. Looking forward, Chemed anticipates continued growth in 2025, with VITAS revenue expected to increase by 10.5% to 11.3%, although Medicare cap limitations may constrain growth. Roto-Rooter is projected to see modest revenue growth as management’s improvement initiatives gain momentum. Overall, the company’s strategic focus on acquisitions and operational efficiency is expected to support its growth trajectory despite some margin pressures.
More about Chemed
YTD Price Performance: 13.50%
Average Trading Volume: 99,572
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $9B